Saroja Pharma Industries India Limited IPO
Saroja Pharma Industries India Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹84 per share. The stock debuted at ₹65. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹1,34,400.
Saroja Pharma Industries India Limited IPO
- IPO Dates
- Aug 31, 2023 – Sep 5, 2023
- Price band
- ₹84 per equity share
- Minimum Investment
- ₹1,34,400
- Issue size
- 1,084,800 shares(aggregating up to ₹9.11 Cr)
- Lot size
- 1600
- Allotment Date
- Sep 11, 2023
- Listing
- Sep 13, 2023
- Listing At
- NSE SME
IPO timeline
-
Aug 31, 2023
Open Date
Completed
-
Sep 5, 2023
Close Date
Completed
-
Sep 11, 2023
Allotment Date
Completed
-
Sep 13, 2023
Listing Date
Completed
Saroja Pharma Industries India Limited IPO Essentials
Saroja Pharma Industries India Limited IPO Details
Saroja Pharma Industries India Limited IPO is priced at ₹84 per share with a total issue size of 1,084,800 shares(aggregating up to ₹9.11 Cr). The IPO has a lot size of 1600 shares and is listed on NSE SME.
- Issue price
- ₹84 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 1,084,800 shares(aggregating up to ₹9.11 Cr)
- Listing at
- NSE SME
- List price
- 65.0
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
Swastika Investmart Ltd
Saroja Pharma Industries India Limited IPO Details
- Retail Portion 50%
Saroja Pharma Industries India Limited IPO Documents
Saroja Pharma Industries India Limited IPO Analytics
Saroja Pharma Industries India Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Saroja Pharma Industries India Limited IPO Subscription Status
Saroja Pharma Industries India Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 515,200 | 515,200 | 1,030,400 |
|
Day 1
31-08-23 06:00 PM
|
(0.11) x | 1.58 x | 0.79 x |
|
Day 2
01-09-23 06:00 PM
|
(0.49) x | 3.75 x | 2.12 x |
|
Day 3
04-09-23 06:00 PM
|
(1.14) x | 7.62 x | 4.39 x |
|
Day 4
05-09-23 06:00 PM
|
(2.90) x | 14.65 x | 8.79 x |
Saroja Pharma Industries India Limited Valuations
Earnings
- EPS (Post IPO)
- ₹3.61/-
- P/E Ratio
- 23.27
Returns
- RoNW
- 20.85%
Saroja Pharma Industries India Limited Financials( In Lakhs)
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Assets | 2,133.99 | 1,551.19 | 822.39 |
| Revenue | 5,035.09 | 5,595.67 | 3,674.67 |
| Profit After Tax | 106.06 | 114.01 | 73.13 |
Saroja Pharma Industries India Limited Company & Offer Insights
About Saroja Pharma Industries India Limited
Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Saroja Pharma Industries India Limited Promoter(s)
Mr. Biju Gopinathan Nair, Mr. Manish Dasharath Kamble are the company's promoters of Saroja Pharma Industries India Limited.
Saroja Pharma Industries India Limited IPO Issue Objectives
- •
- To Set-up a Manufacturing Unit.
- •
- To Repay the Unsecured Loans.
- •
- Public Issue Expenses.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Saroja Pharma Industries India Limited IPO is a Fixed Priced IPO worth ₹1,084,800 shares(aggregating up to ₹9.11 Cr). The issue price is ₹84 per share (fixed price). The IPO opens on Aug 31, 2023 and closes on Sep 5, 2023. It will be listed on NSE SME Platform. Kfin Technologies Limited is the registrar.
The issue price of Saroja Pharma Industries India Limited IPO is ₹84 per share (fixed price).
The lot size of Saroja Pharma Industries India Limited IPO is 1600 shares.
The minimum investment for Saroja Pharma Industries India Limited IPO is approximately ₹1,34,400 based on the issue price .
Saroja Pharma Industries India Limited IPO opens on Aug 31, 2023 and closes on Sep 5, 2023.
The allotment date of Saroja Pharma Industries India Limited IPO is Sep 11, 2023.
Saroja Pharma Industries India Limited IPO is expected to be listed on Sep 13, 2023, on NSE SME Platform.
Saroja Pharma Industries India Limited IPO valuation snapshot: P/E 23.27, EPS ₹3.61/-, P/B N/A, RoNW 20.85%, and market cap N/A.
To apply for Saroja Pharma Industries India Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Saroja Pharma Industries India Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Saroja Pharma Industries India Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Saroja Pharma Industries India Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Saroja Pharma Industries India Limited IPO allotment status on IPO Ji for quick and easy access.